-
STAKEHOLDER CONFIDENCE IN IRELANDS COMMITMENT TO A 180-DAY REIMBURSEMENT TIMELINE
Aug 11, 2026, 17:16 PM -
BEYOND PATIENT OUTCOMES: THE GROWING RECOGNITION OF CAREGIVER IMPACT IN OUTCOMES RESEARCH
Aug 11, 2026, 17:16 PM -
COMPARISON OF VALUE ESTIMATED USING TIME TRADE OFF AND WILLINGNESS TO PAY IN THE TREATMENT OF X-LINKED HYPOPHOSPHATEMIA
Aug 11, 2026, 17:16 PM -
BIOSIMILAR-ENABLED ACCESS AND REPOSITIONING (BEAR): A FRAMEWORK FOR LIFECYCLE ASSESSMENT AND REPOSITIONING OF BIOLOGIC THERAPIES INFORMED BY CROSS-COUNTRY EVIDENCE AND STAKEHOLDER RECOMMENDATIONS
Aug 11, 2026, 17:16 PM -
SOCIETAL IMPACT OF DIABETIC MACULAR EDEMA TREATMENT IN MOROCCO: A DISEASE-LEVEL SOCIAL IMPACT ASSESSMENT USING A HUMAN CAPITAL APPROACH
Aug 11, 2026, 17:16 PM -
A SCENARIO-BASED SIMULATION FRAMEWORK TO BRIDGE EFFICACY TO REAL-WORLD EFFECTIVENESS FOR NEWLY APPROVED THERAPIES
Aug 11, 2026, 17:16 PM -
BRIDGING REAL-WORLD DATA ACROSS BORDERS: A COMPARATIVE MAPPING OF HEALTH DATA RESOURCES IN ALBERTA, CANADA AND ENGLAND
Aug 11, 2026, 17:16 PM -
APPLYING THE GENERALIZED RISK-ADJUSTED COST-EFFECTIVENESS FRAMEWORK TO DERIVE WILLINGNESS-TO-PAY THRESHOLDS FOR ER+/HER2-/ESR1+ METASTATIC BREAST CANCER
Aug 11, 2026, 17:16 PM -
VENTURE-1: IMPACT OF VK2735, A DUAL INCRETIN AGONIST, ON PREDICTED CARDIOVASCULAR DISEASE RISK
Aug 11, 2026, 17:16 PM -
THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS IN TURKIYE: FINDINGS FROM A PATIENT SURVEY ON AWARENESS, DISEASE EXPERIENCE, AND IMMUNIZATION ATTITUDES
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF MALE SLING AND ARTIFICIAL URINARY SPHINCTER FOR URETHRAL SPHINCTER DEFICIENCY IN THAILAND
Aug 11, 2026, 17:16 PM -
MOST FAVOURED NATION, LEAST FAVOURED MARKETS? EU5 PAYER PERSPECTIVES ON US PRICING REFORMS
Aug 11, 2026, 17:16 PM -
THE COST PER RESPONDER OF BIMEKIZUMAB VERSUS RISANKIZUMAB IN PSORIATIC ARTHRITIS (PSA)
Aug 11, 2026, 17:16 PM -
SYSTEMATIC LITERATURE REVIEW OF ADVERSE EVENTS OBSERVED IN THE REAL WORLD WITH ISAVUCONAZOLE, VORICONAZOLE AND LIPOSOMAL AMPHOTERICIN B IN INVASIVE MOLD INFECTION TREATMENTAND LIPOSOMAL AMPHOTERICIN B IN INVASIVE MOLD INFECTION TREATMENT
Aug 11, 2026, 17:16 PM -
PROCUREMENT AND EXPENDITURE TRENDS OF ORPHAN AND NON-ORPHAN HIGH-COST MEDICINES DISPENSED THROUGH PUBLIC OUTPATIENT PHARMACIES IN GREECE, 2020-2025
Aug 11, 2026, 17:16 PM -
UNDERSTANDING EMPLOYMENT AND FINANCIAL CHALLENGES OF CARE PARTNERS OF PEOPLE WITH ALZHEIMER'S DISEASE AND OTHER DEMENTIAS: A MULTI-COUNTRY MIXED METHODS STUDY
Aug 11, 2026, 17:16 PM -
CONVERGENCE OR PLURALISM? TRACKING METHODOLOGICAL TRENDS IN EARLY EU JOINT CLINICAL ASSESSMENTS
Aug 11, 2026, 17:16 PM -
UTILIZATION AND EXPENDITURE TRENDS OF MEDICINES DISPENSED THROUGH PUBLIC OUTPATIENT PHARMACIES IN GREECE: A COMPARISON OF SPECIAL ACCESS AND STANDARD PATHWAYS 2020-2025
Aug 11, 2026, 17:16 PM -
A STRUCTURED FRAMEWORK FOR CONFOUNDER IDENTIFICATION: A CAUSAL INFERENCE APPROACH FOR LOCALIZED OR LOCALLY ADVANCED HIGH-RISK PROSTATE CANCER
Aug 11, 2026, 17:16 PM -
GLOBAL REGULATORY CHALLENGES AND PATIENT SAFETY CONCERNS IN NEW-AGE TECHNOLOGY-BASED MEDICAL DEVICES A SCOPING REVIEW
Aug 11, 2026, 17:16 PM
